NCT05340010View on ClinicalTrials.gov

Administration of Human Chorionic Gonadotrophin Before Secretory Transformation of Frozen-thawed Embryo Transfer Cycles

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

June 20, 2022

Study Completion Date

July 30, 2022

Conditions
hCGFETFrozen-thawed Embryo TransfeHuman Chorionic Gonadotrophin
Interventions
DRUG

Human Chorionic Gonadotrophin Intramuscular injection 10.000 IU

From the 12th to 13th day of the cycle when endometrium reached the optimal thickness ≥8 mm, group 1 (hCG) will receive 10.000 IU hCG intramuscular injection in the morning then vaginal suppository progesterone 400 mg twice a day will be started in the afternoon

Trial Locations (1)

Unknown

Alexandria university, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER

NCT05340010 - Administration of Human Chorionic Gonadotrophin Before Secretory Transformation of Frozen-thawed Embryo Transfer Cycles | Biotech Hunter | Biotech Hunter